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Abstract. The theory of dissolution kinetics of gentamicin from polylactic acid-hydroxyapatite thin 
film composites is spotlighted with the combination of diffusion and polymer degradation 
modeling. The use of various mathematical models, characterizing diffusion, dissolution or/and 
erosion prevalence as well as a mix of dissolution-diffusion rate processes were employed in order 
to compare theory with experimental data. A number of factors influence the release kinetics of 
gentamicin from medical drug release systems and devices. It is difficult to have a single 
mathematical model that takes all these factors into account. It is shown that the degradation of the 
polymer matrix plays the biggest role in the release kinetics of polymer-ceramics thin film 
composites. It was also observed that multistage drug release form these devices depends also on 
the degradation kinetics of the polymer matrix. The effect of pH and device sizes were not studied 
but could also be of interest in future studies. 
Introduction 
Slow drug release has been an important research subject in the field of drug delivery for 
decades. Drug release systems provide an outstanding alternative to conventional clinical therapies. 
The use of biodegradable materials such as polymer and calcium phosphates in designing drug 
release devices provides the outstanding capability of performing localized and controlled delivery 
of drugs to different parts of the host body. In order to allow for greater potency and less toxicity to 
healthy tissue, therapeutic agent release systems are required to control the release. Generally 
speaking in slow drug delivery devices, the mechanisms leading to drug release are linked to 
diffusion, dissolution and erosion of the matrix. However, additional interactions with the carrier 
can also modify the release kinetics. Furthermore, the physicochemical and morphological 
properties, the positioning of the drug within the porous network, its accessibility and its solubility 
are key parameters that govern the release kinetics and therefore the efficiency and efficacy of the 
treatment. There has been an enormous effort directed to the development of biodegradable 
materials that are capable of releasing drugs by reproducible and predictable kinetics [1, 2] to meet 
these demands. 
Ceramics and other materials, such as polymers and biocomposites, have been proposed in the 
past, but it is difficult to shape them appropriately with adequate micro porosity in order to be fitted 
into any type and size of bone defect. Recently it has been demonstrated by Ben-Nissan and co-
workers that marine shells with specific microspherical design offer desired functions for the 
delivery of Bisphosphonate (paminodrate) and antibiotic (Gentamicin) [3]. This has been possible 
by virtue of its unique structure and architecture of the foraminifera shells, which are extraordinarily 
difficult to manufacture with the current know-how [4]. 
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Drug release from biodegradable polymer-ceramic composite is not only due to polymer 
degradation but also the diffusion of the drug entrapped into the polymer matrix, which plays an 
important role depending on the extension of the experiments. Langer [5] defined drug release from 
polymeric materials as the process in which drug solutes migrate from the initial position in the 
polymeric system to the polymer’s outer surface and then to the release medium. There is much 
interest in being able to improve and predict precisely drug bioavailability and controlled drug 
release concentration to be within the therapeutic window in prolonged drug release [6]. The 
assessment of kinetic release from drug delivery devices provides the confidence for predicting the 
release behavior before the release systems are realized. This study focused on understanding 
theoretical phenomenon of drug dissolution based on the experimental results and critical 
assessment of the potential of theoretical modeling. 
Materials and Methods 
Materials 
Coral skeleton samples were obtained from the Great Barrier Reef, QLD Australia by Ben-
Nissan and colleagues, Gentamicin sulfate, Clodronate (Dichloromethylenediphosphonic acid 
disodium salt), Chloroform diammonium hydrogen phosphate (NH4)2HPO4, 98%), and sodium 
hypochlorite (NaClO) were obtained from Sigma Aldrich, Castle Hill, Australia. 
Methods 
Drug loading to the PLA-films and PLA composites was performed based on our previous 
work [7, 8]. Drug release study from the devices were conducted under SINK conditions in 
phosphate buffered saline in a temperature controlled water bath shaker running at a constant speed 
of 100 rpm. Gentamicin concentrations in the solution were determined by using a Cary 100  
UV-Vis spectrophotometer at the maximum absorbance of gentamicin-ophthaldialdehyde complex, 
λmax = 332 nm, using procedures described in [7] .  
Theoretical 
On the basis of the pertinent literature mathematical models were conceived in order to 
predict the temporal development of the drug release over time. The pros and cons of these various 
models is discussed and a critical assessment of the potential of theoretical modeling is made. 
It is worth mentioning that several factors influence the release mechanism, including the type 
of drug, environmental conditions during drug release as well as the geometry and dimensions of the 
drug delivery system, and preparation techniques, in order to mention just a few [9]. The 
assumption taken into consideration here is that the drug particles or particles loaded with drugs are 
dispersed randomly throughout the uniform polymer matrix with known geometry, such that the 
probability of finding drug at any point in the polymer matrix is constant at all positions within the 
matrix itself [10]. Based on previous studies, it was shown that the release behavior of a clinical 
active substance from degradable material follows the common pattern consisting of three stages 
[11, 12]. However, a number of other studies have indicated that the behavior of drug release from 
biodegradable materials can follow two or four stages [9]. The common three stages of drug release 
could briefly be elucidated as follows: 
 
Stage I: At time zero, water or buffer begins to hydrate the matrix, a process that happens 
quickly for the bulk eroding polymer matrices. As the matrix hydrates, encapsulated drug 
adjacent to the matrix surface or on the surface diffuses into the water or buffer in a phase 
reservoir in a phase typically known as ‘‘the initial burst.’’ Its magnitude depends on the 
amount of drugs present adjacent to the matrix and on drug solubility. 
Stage II: As the initial burst release takes place, degradation of the polymer chains begins, 
producing soluble oligomers and increasing chain mobility effectively leading to the 
formation of pores in the polymer matrix. It is believed that heterogeneous degradation of 
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the polymer matrix starts with an amorphous region of polymer matrix leaving behind pores, 
creating a secondary surface porosity favourable for fluid transport phenomena and a further 
pathway for dissociation inside the composite. These pores appear to be essential for 
subsequent release of drugs [13]. The drug release by diffusion through the narrow or 
tortuous pores controls the mass transfer process. Graphical observation of the release 
profile indicates changes in the slope of the curve. 
Stage III: Cumulative growth and coalescence of these pores as degradation of the polymer 
matrix progresses, as the results of water or PBS penetrates into the polymer network and 
hydrolyzes the polymer into more soluble oligomers, providing the channels for the drug to 
be able to diffuse towards the surface of a polymer matrix that would otherwise be too dense 
to allow their passage [13]. The drug is released progressively until complete polymer 
degradation, a process that depends on the polymer degradation behavior. In our case, the 
duration of the experiments for gentamicin loaded polymers were 15 [8], which is 
insufficient time to achieve complete full degradation. 
 
For four stage drug release behavior it has been proposed to have a secondary boost before the 
final stages of drug release from the biodegradable matrix. These stages relate to the pure polymeric 
matrix and addition of the particulate matter as drug carrier introduces additional stages to the 
process, which will be discussed in the following section. 
Results and Discussion 
The release kinetic study was assessed by a model dependent method. Based on a number of 
different kinetic models available in literature, which described the overall release of drug from the 
dosage forms, the models were carefully selected and used to fit the release data [14-17]. Finally, 
data was fitted to seven different models: Zeroth order, first Order, Higuchi, Hixson-Crowell, 
Korsmeyer-Peppas and Reciprocal powered time. The correlation coefficients (r2) indicate that drug 
release kinetic of polylactic acid loaded with gentamacin (PLAGM) and Polylactic acid 
hydroxyapatite loaded with gentamicin (PLAHApGM) fitted with the power law model described 
by Korsmeyer-Peppas (Table 8). If this semi-empirical equation does not allow for the 
determination of all of the mechanisms involved in the release, it is still possible to determine the 
mechanisms of transport by considering two borderline cases, which correspond to distinct physical 
realities (when n = 0.5 and n = 1). The coefficient n obtained for PLAGM (n < 0.5) indicates that 
the release mechanism was mainly controlled by diffusion while the value obtained for 
PLAHApGM (n > 1) is characteristic of a number of mixed transport mechanisms including 
diffusion, possibly super case II kinetics as well as a release due to damage to the composite surface 
through dissolution. 
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Table 1: Modelled dissolution characteristics of the mean dissolution profile [8] 
  
F = fraction of drug released up to time t, r2 = square correlation coefficient, Qo, ko, k, a, b, n, m and b are 
parameters of the models. 
Stage I 
The initial very quick release (burst) of gentamicin (GM) can be assimilated as direct dissolution 
of drugs in water. It is shown in Figure 1 that the initial burst took only one week for gentamicin. At 
this stage it can be assumed that the release is purely governed by diffusion of drugs from polymer 
surfaces [18, 19]. 
Stage II 
This step is driven by the internal diffusion of drugs impregnated within the matrix possibly in 
the porous part of the matrix generated during preparation. For gentamicin release from 
PLAHApGM samples, this stage is preceded by a “lag phase” which occurs between 1 and 2 hours 
of release. The presence of HAp loaded with gentamicin could in many ways hinders or slows down 
the release of gentamicin through these micropores. This stage is a bit slower release compared to 
the previous one due to the drug transporting through these small and narrow pores. 
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Figure 1: Fractional cumulative release of gentamicin from polylactic acid (PLA) thin film 
composite in phosphate buffered saline (PBS) solution (pH 7.4, 37 °C and 100 rpm), for fifteen 
weeks. Error bars are mean standard deviation (SD) of triplicate experimental data  
Table 2: Specific time frames for different release stages and their numerical values for gentamicin 
(Three stages)  
Type of drug released Stages to (w) tf (w) 
Gentamicin 
Stage I (burst ext. release) 0 1 
Stage II (Internal release) 1 3 
Stage II (lag phase) 3 5 
Stage III (degradation) 5 ∞ 
Lag stage (Sub stage II) 
This is a ‘lag stage or phase’ for devices loaded with gentamicin. The lagging to release a 
significant amount of drug from the devices could be attributed to the pH change of entrapped, 
released acidic degradation products from the polymer matrix. The acidic environment would 
trigger unfolding of the encapsulated gentamicin until the degradation products dissolve and diffuse 
to the outer surface of the matrix providing a way for the drugs to be released [20]. 
Stage III 
This is the terminal release stage for gentamicin-loaded devices. After a greater fraction of the 
drug is released, the remaining drug release is directly associated with polymer degradation [21]. 
There is the possibility of drug release by conventional diffusion at this stage, but it is considered to 
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be negligible compared to that released by polymer degradation. In this study, it was observed that 
this stage was the slowest and steady stage drug release phase. 
Dissolution profiles of gentamicin released from PLA film and PLA-Hydroxyapatite composite 
were compared by using a statistical difference factor (f1), and a similarity factor (f2). The test 
indicates that there is a significant statistical difference between the two kinetic profiles. This 
difference is confirmed by the release half-life (t50%) obtained for each material loaded with 
gentamicin. Thus, the release half-life from PLA film was obtained around 14 days while 124 days 
were necessary for PLA composite [8]. The difference between PLAGM and PLAHApGM 
regarding the amount of drug released is due to the fact that corolline HAp contains nano and meso 
pores in which drug goes into them and reduces drug accessibility during dissolution. HAp particles 
takes longer to dissociate than PLA. 
Conclusions 
Drug release mechanism from biodegreadable polymer-ceramic composites is a complex 
phenomenon which can not be defined by a single mathematical model. Precise prediction of release 
profiles is very important. Theoretical release mechanism presented in this paper took in 
consideration all aspects of polymer and ceramic behavior in phosphate baffered saline with an 
assumption of no strong affinity between drug and ceramics/polymer. The theory seemed to agree 
with the experimental data in our previous work. The research on PLA-ceramics thin film 
composites as the slow drug delivery devices reveals possible potential applications in biomedical 
field.  
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